News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

iCAD, Inc. (ICAD) Announces Positive Three-Year Data Using the Xoft System to Treat Skin Cancer Presented at ASTRO



9/25/2013 6:35:07 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Booth Number 2449 – iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that positive data using the Company’s Xoft® Axxent® Electronic Brachytherapy System® to treat non-melanoma skin cancer (NMSC) were presented today at the American Society of Radiation Oncology’s (ASTRO) 55th Annual Meeting being held from September 22-25, 2013 in Atlanta.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES